Singling Out RNA Biomarkers in Situ
ACD’s ISH Platform Achieves Single-Base Resolution and Retains Morphological Context
Microanalyte MDx Goes Mainstream
Nucleic Acid Analytes Are Reliable Sources of Data for Diagnostic Calculations
Continuous Bioprocessing Skips a Beat
Bioprocessing Needs a Tuneup If It Is to Run Smoothly and At Full Power
Counting on Faster Flow Cytometry
In Flow Cytometry, “Fast” Is About Speedily Collecting and Analyzing Data
For full access to this article login to GEN Select now.
Biobank Diversity Facilitates Drug & Diagnostic Development
- The biobanking market, estimated at $7.88 billion by Visiongain, is poised to expand as researchers continue to migrate toward the use of human tissues and biomaterials for primary research, and pharmaceutical and diagnostic-tool development. A large and difficult-to-estimate number of facilities, ranging from individual research laboratories to hospitals, ...
Not registered yet? Please fill out the form below and enjoy complimentary access to this and an exclusive collection of premium content and personalization features as a GEN Select insider. Learn More.
Get GEN Select Access Now
- Do not put any letters or characters here if you are not a spy program.